Related Experiment Videos
Overview: from heparin to low molecular weight heparin: beyond anticoagulation
1DuPont Pharmaceuticals Co, Experimental Station, Wilmington, DE 19880-0400, USA. shaker.a.mousa@dupontpharma.com
Current Opinion in Investigational Drugs (London, England : 2000)
|March 15, 2002
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Do blood constituents in varicose veins differ from the systemic blood constituents?
European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery·2015
Elevated endocan levels and its association with clinical severity in Stevens-Johnson Syndrome and toxic epidermal necrolysis.
International angiology : a journal of the International Union of Angiology·2014
Pharmacological profile of sulodexide.
International angiology : a journal of the International Union of Angiology·2014
Medical management of patients with peripheral arterial disease.
International angiology : a journal of the International Union of Angiology·2014
Prevention and treatment of venous thromboembolism--International Consensus Statement.
International angiology : a journal of the International Union of Angiology·2014
Association between serum levels of pro-metalloproteinase 1, tissue inhibitor of metalloproteinases 1 and 2 and prevalent cardiovascular disease in a population-based study.
International angiology : a journal of the International Union of Angiology·2013
Reporting disease control rates or clinical benefit rates in early clinical trials of anticancer agents: useful endpoint or hype?
Current opinion in investigational drugs (London, England : 2000)·2011
Abating progressive tissue injury and preserving function after CNS trauma: The role of inflammation modulatory therapies.
Current opinion in investigational drugs (London, England : 2000)·2010
Teriflunomide, an inhibitor of dihydroorotate dehydrogenase for the potential oral treatment of multiple sclerosis.
Current opinion in investigational drugs (London, England : 2000)·2010
Tralokinumab, an anti-IL-13 mAb for the potential treatment of asthma and COPD.
Current opinion in investigational drugs (London, England : 2000)·2010
Vedolizumab, a humanized mAb against the α4β7 integrin for the potential treatment of ulcerative colitis and Crohn's disease.
Current opinion in investigational drugs (London, England : 2000)·2010
Pitrakinra, a dual IL-4/IL-13 antagonist for the potential treatment of asthma and eczema.
Current opinion in investigational drugs (London, England : 2000)·2010
Atypical immune dysfunction in G6PD deficiency: a case of mosaic neutrophil oxidative burst.
Proceedings (Baylor University. Medical Center)·2026
Retrieval Strategies for Embolized Left Atrial Appendage Closure Devices.
JACC. Case reports·2026
Glycoprotein 1bM assay and von Willebrand disease: a change in diagnosis.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis·2026
Outcomes of patients with hematological malignancies complicated with autoimmune diseases after allogeneic hematopoietic stem cell transplantation: A ten-year real-world study.
Journal of translational internal medicine·2026
Acquired hemophilia A: an illustrated review based on the French National Guidelines.
Research and practice in thrombosis and haemostasis·2026
Occult haemorrhagic shock due to hemomediastinum following percutaneous coronary intervention: a case report.
European heart journal. Case reports·2026